March 30, 2011 @ 05:49 am Isogenica Opens North American Office
Isogenica has established a dedicated business development and customer support team based in Alameda, CA. The team will provide direct support to existing and prospective customers in the U.S. and Canada. According to a company statement, "This latest development ensures Isogenica is now well positioned to address the antibody, protein and peptide engineering needs of its rapidly growing user base across North America."
The company also announced the appointment of Garry Merry as Business Development Consultant for North America. Before joining Isogenica, Mr. Merry was with Sloning Biotechnologies, where he was instrumental in establishing its gene library technology for antibody development and protein engineering. He has also held senior executive positions with other successful life science companies, such as Applied Biosystems, Millipore and Qiagen.
Dr Kevin Matthews, Isogenica's chief executive officer, remarked, The creation of our new North American office is a critical milestone in the maturation of the company. Isogenica has already experienced significant success in 2011, with Johnson & Johnson Pharmaceutical Research Division. For established as well as prospective clients we understand that direct personal contact is fundamental to the proposition as well as essential for us to achieve our overall growth potential as a company. I am delighted that Garry will be underpinning our efforts in North America. He has an excellent knowledge of the market, and has established relationships with most of the key players in the field of antibody engineering, I look forward to his contribution.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)